Combination Chemotherapy and Nelarabine for T-cell Acute Lymphoblastic Leukemia/Lymphoma
Phase 2
160
about 19 years
All ages
1 site in TX
What this study is about
This trial is testing a treatment of combination chemotherapy with nelarabine to see how well it works in treating patients with T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. The treatment uses different drugs that stop cancer cell growth by killing, stopping division, or preventing spread.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Cyclophosphamide
- 2.Take Cytarabine
- 3.Take Dexamethasone
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
cyclophosphamide (Alkylating chemotherapy; crosslinks DNA strands), cytarabine, dexamethasone, Antineoplastic Agent [TC] (Topoisomerase 2 Inhibitors), mercaptopurine, methotrexate, nelarabine, pegaspargase
infusion, injection (Injection), injection, ocular, oral (Oral Tablet), oral
Primary: Complete remission rate, Overall survival, Progression-free survival
Oncology